OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiac fibrosis
Nikolaos G. Frangogiannis
Cardiovascular Research (2020) Vol. 117, Iss. 6, pp. 1450-1488
Open Access | Times Cited: 710

Showing 1-25 of 710 citing articles:

Transforming growth factor-β in myocardial disease
Nikolaos G. Frangogiannis
Nature Reviews Cardiology (2022) Vol. 19, Iss. 7, pp. 435-455
Closed Access | Times Cited: 186

Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Xingpeng Di, Xiaoshuai Gao, Liao Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 153

Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)
Huifei Su, Sharpkate Shaker, Yi Kuang, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 4, pp. 1999-2038
Closed Access | Times Cited: 124

Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 123

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Kazuaki Maruyama, Kyoko Imanaka‐Yoshida
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2617-2617
Open Access | Times Cited: 112

Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing
Ye Liu, Yiqiu Liu, Wenjie He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 93

Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions
Nicola Riccardo Pugliese, Pierpaolo Pellicori, Francesco Filidei, et al.
Cardiovascular Research (2022) Vol. 118, Iss. 18, pp. 3536-3555
Open Access | Times Cited: 73

Cardiac fibroblasts and mechanosensation in heart development, health and disease
Maurizio Pesce, Georg N. Duda, Giancarlo Forte, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 309-324
Closed Access | Times Cited: 69

Immunology of human fibrosis
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 63

A Cardiac‐Targeted Nanozyme Interrupts the Inflammation‐Free Radical Cycle in Myocardial Infarction
Xueliang Liu, Binghua Chen, Jingqi Chen, et al.
Advanced Materials (2023) Vol. 36, Iss. 2
Closed Access | Times Cited: 52

Fir(e)ing the Rhythm
Pietro Enea Lazzerini, Antonio Abbate, Mohamed Boutjdir, et al.
JACC Basic to Translational Science (2023) Vol. 8, Iss. 6, pp. 728-750
Open Access | Times Cited: 47

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41

The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
Yuling Wang, Linke Jiao, Caoxia Qiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116116-116116
Open Access | Times Cited: 27

ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice
Tao Zhuang, Meihua Chen, Ruo-Xi Wu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26

Targeting immune–fibroblast cell communication in heart failure
Junedh M. Amrute, Xin Luo, Vinay Penna, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 423-433
Closed Access | Times Cited: 26

Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction
Meiyan Sun, Mao Sui, Chao Wu, et al.
Circulation (2024) Vol. 149, Iss. 19, pp. 1516-1533
Closed Access | Times Cited: 21

Direct interrogation of context-dependent GPCR activity with a universal biosensor platform
Remi Janicot, Marcin Maziarz, Jong‐Chan Park, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1527-1546.e25
Open Access | Times Cited: 21

Endothelial cells drive organ fibrosis in mice by inducing expression of the transcription factor SOX9
Felix A. Trogisch, Aya Abouissa, Merve Keleş, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Open Access | Times Cited: 18

Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 86

Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
Jorge Gutiérrez‐Cuevas, Ana Sandoval-Rodríguez, Alejandra Meza-Ríos, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 629-629
Open Access | Times Cited: 77

Inflammation in Metabolic Cardiomyopathy
Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 69

Single-cell transcriptomics for the assessment of cardiac disease
Antonio M. A. Miranda, Vaibhao Janbandhu, Henrike Maatz, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 5, pp. 289-308
Open Access | Times Cited: 61

Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target
Katharina Schimmel, Kenzo Ichimura, Sushma Reddy, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 54

Page 1 - Next Page

Scroll to top